AIRLINK 74.00 Decreased By ▼ -0.56 (-0.75%)
BOP 5.04 Decreased By ▼ -0.02 (-0.4%)
CNERGY 4.45 Decreased By ▼ -0.01 (-0.22%)
DFML 42.20 Increased By ▲ 2.47 (6.22%)
DGKC 86.91 Decreased By ▼ -0.64 (-0.73%)
FCCL 21.75 Decreased By ▼ -0.18 (-0.82%)
FFBL 34.89 Increased By ▲ 0.30 (0.87%)
FFL 10.03 Increased By ▲ 0.28 (2.87%)
GGL 10.48 Decreased By ▼ -0.01 (-0.1%)
HBL 113.68 Decreased By ▼ -0.11 (-0.1%)
HUBC 136.02 Decreased By ▼ -0.50 (-0.37%)
HUMNL 11.90 Increased By ▲ 1.00 (9.17%)
KEL 4.78 Increased By ▲ 0.11 (2.36%)
KOSM 4.62 Decreased By ▼ -0.02 (-0.43%)
MLCF 38.00 Decreased By ▼ -0.46 (-1.2%)
OGDC 135.89 Decreased By ▼ -0.25 (-0.18%)
PAEL 26.71 Increased By ▲ 0.10 (0.38%)
PIAA 20.80 Decreased By ▼ -1.69 (-7.51%)
PIBTL 6.73 Increased By ▲ 0.06 (0.9%)
PPL 122.65 Increased By ▲ 0.36 (0.29%)
PRL 26.96 Decreased By ▼ -0.01 (-0.04%)
PTC 14.47 Increased By ▲ 0.56 (4.03%)
SEARL 59.50 Decreased By ▼ -0.37 (-0.62%)
SNGP 70.15 Increased By ▲ 0.09 (0.13%)
SSGC 10.34 Decreased By ▼ -0.01 (-0.1%)
TELE 8.65 Increased By ▲ 0.11 (1.29%)
TPLP 11.25 Decreased By ▼ -0.09 (-0.79%)
TRG 65.20 Decreased By ▼ -0.80 (-1.21%)
UNITY 26.17 Decreased By ▼ -0.16 (-0.61%)
WTL 1.35 No Change ▼ 0.00 (0%)
BR100 7,860 Increased By 35.3 (0.45%)
BR30 25,402 Decreased By -3.7 (-0.01%)
KSE100 75,316 Increased By 232.1 (0.31%)
KSE30 24,175 Increased By 81.7 (0.34%)

Barclays Capital, the investment banking arm of Britain's Barclays Plc, has dropped plans to bid for stockbroker Cazenove but may reconsider at a lower price, a source familiar with the situation said.
The source said that senior management at Barclays Capital had been keen to bid for the 180-year old broker but that they were not prepared to pay the price Cazenove is seeking.
"They (Barclays Capital) could not make the numbers work and have agreed to walk away ... with the idea that if the price changes (falls) they (Barclays) may come back," the source said.
Cazenove, which has an estimated price tag of around 750-800 million pounds, last month said it is considering several take-over approaches but that it would still prefer to pursue a stock market flotation. Still, Barclays' withdrawal will narrow options for Cazenove chief David Mayhew and could clear the way for rival suitor Lehman Brothers to negotiate a deal.
The source said Barclays Capital saw Cazenove as a strong fit for the UK bank that could bolster its growing equity products business and give the debt-focused bank a new UK corporate finance business. Barclays declined to comment and Cazenove could not immediately be reached for comment.
Cazenove has been unofficially up for sale since it announced plans for a flotation in 2001 but its profits were then hit by a painful downturn in equity markets and three years on it is still looking for a buyer.
Sources say possible bidders are concerned that the UK broker could prove expensive if Cazenove's extensive client list, which includes nearly 50 blue chip companies in the FTSE 100 index, defects after a take-over or when Mayhew retires.
Many US investment banks see UK corporate broking as an essential ingredient to growth in UK investment banking but so far none have been prepared to pay up for Cazenove and some have looked for other ways to build a broking franchise.
Banks like Morgan Stanley have gone for the cheaper option, building up a corporate broking team by poaching bankers from rivals like Merrill Lynch.

Copyright Reuters, 2004

Comments

Comments are closed.